Literature DB >> 15072846

Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents.

Eliana Cabrera1, Hugo Cerecetto, Mercedes González, Dinorah Gambino, Pabla Noblia, Lucía Otero, Beatriz Parajón-Costa, Atilio Anzellotti, Roberto Sánchez-Delgado, Amaia Azqueta, Adela López de Ceráin, Antonio Monge.   

Abstract

Complexes of the type [Ru(II)Cl(2)(DMSO)(2)L], where L are 5-nitrofurylsemicarbazone derivatives, were prepared in an effort to combine the potential anti-tumor activity of the metal and the free ligands. The new complexes are excellent DNA binding agents for calf thymus DNA. So, their in vitro anti-tumor activity was tested in cellular models and the complexes were found to be non-cytotoxic on the tumor cell lines assayed, neither in aerobic conditions nor in the bio-reductive assay performed. Redox behavior, lipophilicity and stability were studied in order to explain the lack of cellular cytotoxic effects. The complexes resulted 10-100 times more hydrophilic than the parent ligands thus the bio-activity of these compounds would be compromised by their inadequate lipophilic properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15072846     DOI: 10.1016/j.ejmech.2004.01.002

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Risedronate metal complexes potentially active against Chagas disease.

Authors:  Bruno Demoro; Francesco Caruso; Miriam Rossi; Diego Benítez; Mercedes Gonzalez; Hugo Cerecetto; Beatriz Parajón-Costa; Jorge Castiglioni; Melina Galizzi; Roberto Docampo; Lucía Otero; Dinorah Gambino
Journal:  J Inorg Biochem       Date:  2010-08-14       Impact factor: 4.155

2.  Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity.

Authors:  Bruno Demoro; Andreia Bento-Oliveira; Fernanda Marques; João Costa Pessoa; Lucía Otero; Dinorah Gambino; Rodrigo F M de Almeida; Ana Isabel Tomaz
Journal:  Molecules       Date:  2019-08-07       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.